Drug absorption studies of prodrug esters using the Caco-2 model: evaluation of ester hydrolysis and transepithelial transport

被引:50
作者
Augustijns, P [1 ]
Annaert, P [1 ]
Heylen, P [1 ]
Van den Mooter, G [1 ]
Kinget, R [1 ]
机构
[1] Katholieke Univ Leuven, Lab Farmacotechnol & Biofarm, B-3000 Louvain, Belgium
关键词
Caco-2; ester prodrugs; esterase activity; intestinal absorption;
D O I
10.1016/S0378-5173(98)00013-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The design of lipophilic ester prodrugs is a widely used approach to obtain enhanced oral delivery of poorly membrane permeable compounds. The present study was conducted in order to assess the influence of intestinal metabolism on transepithelial flux of prednisolone prodrugs using the Caco-2 system. In addition, distribution of esterase activity along the GI tract was evaluated using homogenates of scraped intestinal mucosa from various parts of small intestine and colon of rat and pig. Prednisolone acetate (lipophilic prodrug) and prednisolone hemisuccinate (hydrophilic prodrug) were selected as model compounds for transport studies. In transport studies using prednisolone acetate (100 mu M), almost complete ester hydrolysis and an increased transepithelial flux of prednisolone were observed. Virtually no transport nor metabolism was observed when the hemisuccinate ester was used, illustrating its poor ability to cross membranes. Incubation studies with purified carboxylesterase showed that prednisolone acetate was rapidly degraded (t(1/2) = 2.94 min), while prednisolone hemisuccinate degradation was very low. Studies on site dependency of esterase activity using p-nitrophenyl acetate as a substrate showed an important interspecies difference, rat intestine possessing much higher activity than pig intestine, and a gradual decrease of esterase activity along the GI tract for the two species tested. Esterase activity in Caco-2 monolayers was twice as high as observed in colon of rat and pig, but much lower than activities measured in the small intestine. It can be concluded that the rat may not be a suitable choice for oral bioavailability studies of ester prodrugs; it may also be advantageous to target ester prodrugs of hydrophilic compounds to the colon, thus preventing significant accumulation of the parent compound inside the mucosal cells. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:45 / 53
页数:9
相关论文
共 15 条
  • [1] Transport, uptake, and metabolism of the bis(pivaloyloxymethyl)-ester prodrug of 9-(2-phosphonylmethoxyethyl)adenine in an in vitro cell culture system of the intestinal mucosa (Caco-2)
    Annaert, P
    Kinget, R
    Naesens, L
    deClercq, E
    Augustijns, P
    [J]. PHARMACEUTICAL RESEARCH, 1997, 14 (04) : 492 - 496
  • [2] [Anonymous], 1971, The Enzymes
  • [3] THE USE OF CULTURED EPITHELIAL AND ENDOTHELIAL-CELLS FOR DRUG TRANSPORT AND METABOLISM STUDIES
    AUDUS, KL
    BARTEL, RL
    HIDALGO, IJ
    BORCHARDT, RT
    [J]. PHARMACEUTICAL RESEARCH, 1990, 7 (05) : 435 - 451
  • [4] PRODRUGS FOR THE IMPROVEMENT OF DRUG ABSORPTION VIA DIFFERENT ROUTES OF ADMINISTRATION
    BALANT, LP
    DOELKER, E
    BURI, P
    [J]. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1990, 15 (02) : 143 - 153
  • [5] ORAL ABSORPTION OF 21-CORTICOSTEROID ESTERS - A FUNCTION OF AQUEOUS STABILITY AND INTESTINAL ENZYME-ACTIVITY AND DISTRIBUTION
    FLEISHER, D
    JOHNSON, KC
    STEWART, BH
    AMIDON, GL
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1986, 75 (10) : 934 - 939
  • [6] Prodrugs of phosphates and phosphonates: Novel lipophilic alpha-acyloxyalkyl ester derivatives of phosphate- or phosphonate containing drugs masking the negative charges of these groups
    Friis, GJ
    Bundgaard, H
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 1996, 4 (01) : 49 - 59
  • [7] USE OF CACO-2 CELLS AS AN IN-VITRO INTESTINAL-ABSORPTION AND METABOLISM MODEL
    GAN, LS
    EADS, C
    NIEDERER, T
    BRIDGERS, A
    YANNI, S
    HSYU, PH
    PRITCHARD, FJ
    THAKKER, D
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1994, 20 (04) : 615 - 631
  • [8] Development and validation of a pig model for colon-specific drug delivery
    Gardner, N
    Haresign, W
    Spiller, R
    Farraj, N
    Wiseman, J
    Norbury, H
    Illum, L
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1996, 48 (07) : 689 - 693
  • [9] HIDALGO IJ, 1989, GASTROENTEROLOGY, V96, P736
  • [10] CACO-2 CELL MONOLAYERS AS A MODEL FOR DRUG TRANSPORT ACROSS THE INTESTINAL-MUCOSA
    HILGERS, AR
    CONRADI, RA
    BURTON, PS
    [J]. PHARMACEUTICAL RESEARCH, 1990, 7 (09) : 902 - 910